Leadership & Motivation

Size: px
Start display at page:

Download "Leadership & Motivation"

Transcription

1 PROMOTING HEALTH CHILDREN, FAMILY & COMMUNITY Leadership & Motivation ACC-New York, Dec. 11, 2015 No Disclosures

2 Documents on Global CV Health Follow-up? Promoting Cardiovascular Health in the Developing World; A Critical Challenge to Achieve Global Health. Ed. V Fuster and B Kelly. IOM of the Natl. Academies. Natl. Academies Press. Washington DC.2010.

3 Institute of Medicine Experience A Critical Challenge to Achieve Global Health 2011 June Circ. 2011;123: RECOMMEDATIONS

4 FUNDING THE FIGHT AGAINST CHRONIC NCD Sense of Need - Local, National and International Government, Non-Profit Private, For-Profit Private, Partnerships

5 EDUCATION & LOCAL DATA Census-Based, Survey-Based, Study-Based - Great Impact

6 PROMOTING HEALTH CHILDREN, FAMILY & COMMUNITY Leadership & Motivation ACC-New York, Dec. 11, 2015 No Disclosures

7 Health & Quality of Life (QoL) Aging (A) to Birth (B) B Present Health (QoL) Early Economic Late Expensive Policy Mandatory (?) Air Pollution & Noise A 0 B Prom. Health Subcl. Disease Science Future Stable-Unst. Disease A Environment V Fuster, JACC 2015 (October) B Window Behav. Young Change 0 Education Adherence Simplicity A

8 Child s Brain Development Less Networking Brings Atention 1B JN Giedd. Scientific American 2015;312:32

9 COLOMBIA CHILDREN S PROGRAM EDUCATIVE GOAL: HEALTHY HABITS FOR CHILDREN BETWEEN 3 & 5 YRS CHILDREN GENERAL PUBLIC

10 Score (mean) 1. In Children s KAH Mean Scores* p< p< p< p< p< Knowledge Attitudes Habits (physical activity) The Amer J of Med 2012; 126, 27 The Amer J of Med 2013;126:1122 Bogota 25,000

11 2. Changes In Anthropometric Variables At Each FU In Overweight Children Body Mass Index (BMI) Waist Circumference (WC) JL Peñalvo, V Fuster et. al. JACC 2015 (In Press). - 75,000,

12 PROMOTING HEALTH CHILDREN, FAMILY & COMMUNITY Leadership & Motivation ACC-New York, Dec. 11, 2015 No Disclosures

13 Health & Quality of Life (QoL) Aging (A) to Birth (B) B Present Health (QoL) Early Economic Late Expensive Policy Mandatory (?) Air Pollution & Noise A 0 B Prom. Health Subcl. Disease Science Future Stable-Unst. Disease A Environment V Fuster, JACC 2015 (October) B Window Behav. Young Change 0 Education Adherence Simplicity A

14 Subclinical Disease (N=10,000) Carotid 3D-US, Coronary Calcification U Baber, R Mehran, V Fuster, et al. J. Am. Coll. Card. 2015; 65: 1065 L Fernandez-Friera, A Fernandez-Ortiz, V Fuster et.al Circ 2015, 4/20

15 A Health Center In The Adult Brain (?) c 2B? To Stimulate / Motivate

16 1. AMPATH Centers In Kenya BP Control / Non MD / High Technology R Vedanthan, V Fuster, NHLBI / Kenya Model ( )

17 2a. CARDONA INTEGRAL FIFTY-FIFTY SMOKING OVERWEIGHT SEDENTARISM HYPERTENSION TOTAL HABIT SCORE 8 SIX MONTHS 95% of the people have improved in one or more of the habits or RF.

18 2b.The Seven Community Study N= E. Gomez, V Fuster et al 2015 (Subm) Approach 3: PESA Program, Madrid AHA 2015, Orlando

19 2c. Global Demonstration Project - GHP High Risk Factor Profile

20 2c. GHP-CHANGE Grenada Heart Project Community Health ActioN to EncouraGe Healthy BEhaviors. >1 CV Risk Frs N=402 R Monthly Group Meetings Self- Management 12 month GHP Outcomes Score 12 month GHP Outcomes Score Planning Baseline Assessment Group Meetings Midpoint Assessment Post-Interv. Assessment August/Sept 2014 Completed March 2015 Ongoing currently August/Sept 2015 March/April 2016

21 Health & Quality of Life (QoL) Aging (A) to Birth (B) B Present Health (QoL) Early Economic Late Expensive Policy Mandatory (7) Air Pollution & Noise A 0 B Prom. Health Subcl. Disease Science Future Stable-Unst. Disease A Environment V Fuster, JACC 2015 (October) B Window Behav. Young Change 0 Education Adherence Simplicity A

22 1. DBD/AD - CVRFs, Lacunar Les., < Cognitive MRI Perfusion Ischemia affects 60 to 90% of patients with Alzheimer s 1.V Novak, I Hajjar. Nat. Rev. Cardiol. 2010; 7:686(HMS) 2. HW Querfurth, FM LaFerla. NEJM 2010; 362:329 Autopsy (n=6000) 3B 3. JB Toledo et al. Brain July 10, 2013 CV Risk Factors, Cognitive Function, Imaging 4. CARDIA (K Yaffe et al) Circ (In Press) 5.JI Friedman, V Fuster et. al JACC CV Imag (In Press) Intervention 6. FINGER (T Ngandu et al)., The Lancet 2015; 385:2255

23 2. Aging / Frailty Oxidative Stress on Telomere B Niemann et. al. JACC 2011; 57: 577. R Madonna, R De Caterina et. al EHJ 2011;32:1190 (Houston &Chieti, Italy) JC Kovacic, EG Nabel, V Fuster Circ. 2011;123:1650

24 3. CV Drugs Underuse - Polypill, 2ary Prevention. FOCUS 1 & 2 Argentina Brazil Paraguay Italy Spain FREEDOM AETNA-DIABETES SECURE-EC 2015 BIO-EQUIVALENCE PHARMACODINAMIC INTERACTION WITH RAMIPRIL PHARMACODYNAMIC INTERACTION WITH SYMVASTATIN FOOD INTERACTION PHARMACOKINETIC INTERACTION WITH ASPIRIN ASA, Statin, ACE-Inhibitor PHARMACOKINETIC INTERACTION WITH SYMVASTATIN PHARMACOKINETIC INTERACTION WITH RAMIPRIL Am. H J 2011;162:811 Semin.Thor.Cardiov.Surg 2011;23:24 JACC, 2014; 64:2071 PHARMACODYNAMIC INTERACTION WITH ASPIRIN Approved in 26 Countries * Valentín Fuster (inventor)

25 Science, Health, Education(SHE) Colombia / Spain Behavior 2 Kenya/Spain/Grenada. Five Countries IIIP / PPPI Polypill Extended healthy lives in part due to medical research generates dramatic returns - Albert & Mary Lasker Found

26 American Heart Association, Focused Prevention Research Center Family-Based Approach Prevention of CVD in a Minority Community Integrating Systems-Biology Icahn School of Medicine at Mount Sinai

27 Head Start Organization

28 Start (1) Children 3 Groups Caregivers 3 Groups (2) Start KAH-BEA Mol. Genomics KAH-BEA S-KAH-BEA P P P P P P O I I (3) I O O Teachers O IP II BEWAT Point of Care. 3D-US Mol. Genomics O O O O IP II BEWAT Point of Care 3D-US Mol. Genomics O O O 1 st Yr 2 nd Yr 3 rd Yr 4 th Yr (3) O O O (1) Contr./Interv. Intervention. Intervention Control PPPI IIIP (2) S-BEWAT Point of Care KAH-BEA = Knowledge, Attitude, Habit -BMI, Exercise, Alimentation PPPI = Peer-to-Peer Program Interv; IIIP = Intensive Individual Intervention Program BEWAT = BP, Exercise, Weight, Alimentation, Tobacco

29 Wearable Tech

30 Interactive Circle of Health - App Actividades previstas Lanzamiento de la versión internacional THE CIRCLE OF HEALTH

31 Engaging Partners Mount Sinaí Heart FC Barcelona

32 PROMOTING HEALTH CHILDREN, FAMILY & COMMUNITY Leadership & Motivation ACC-New York, Dec. 11, 2015 No Disclosures

33 HEALTH ENVIRONMENT SCIENCE EDUCATION

34 Continuity EDUCATION CARDONA HARLEM GRENADA KENYA MADRID BOGOTA Community Family Adults Children

35 PROMOTING HEALTH A CHALLENGE FOR SCIENCE & EDUCATION Leadership & Motivation ACC-New York, Dec. 11, 2015 No Disclosures

The Three Upcoming Challenges

The Three Upcoming Challenges From Aging/Disease to Youth/Health Economic, Scientific, Educational The Three Upcoming Challenges New York, Dec 9, 2016 No Disclosures NHLBI Strategic Agenda - 2025 M Lauer, GH Gibbons et. al. JACC 2015;

More information

Imaging Omics Behavior

Imaging Omics Behavior Scientific Bases of Health Subclinical Systemic Disease Imaging Omics Behavior ACC New York, Dec 8, 2017 No Disclosures From Aging / Disease to Youth / Health Primordial 00-25 yrs NHLBI $-1 Primary 25-50

More information

SCIENCE, HEALTH, EDUCATION. 4 Ts, 4 As

SCIENCE, HEALTH, EDUCATION. 4 Ts, 4 As SCIENCE, HEALTH, EDUCATION 4 Ts, 4 As SHE, Community, All Ages The Circle of Leadership Valentín Carulla President Barcelona University (1913-23) SCIENCE, HEALTH, EDUCATION 4 Ts, 4 As 1. UN Targets Top

More information

Better CABGs vs Better PCI Devices

Better CABGs vs Better PCI Devices CABG vs PCI 2017 Multivessel Coronary Disease Better CABGs vs Better PCI Devices ACC New York, Dec 8, 2017 No Disclosures CABG vs PCI 2017 Stable Multivessel Coronary Disease 1. Are These The two Critical

More information

The Evolving Science of Health Imaging, Genetics and Behavior. The Heart and the Brain

The Evolving Science of Health Imaging, Genetics and Behavior. The Heart and the Brain The Evolving Science of Health Imaging, Genetics and Behavior The Heart and the Brain Lima, Nov 17, 2018 No Disclosures From Aging / Disease to Youth / Health Primordial 00-25 yrs NHLBI $-1 Primary 25-50

More information

Complex CAD (5) PVD-P Valv. CM. Sub-Clinical Arterial (2) DBD/Frailty (2) Health Political (1) Personal (3)

Complex CAD (5) PVD-P Valv. CM. Sub-Clinical Arterial (2) DBD/Frailty (2) Health Political (1) Personal (3) 1. A Transition From Disease to Health 2. Heart Brain Integration 3. Imaging / Omics / Regeneration / Life Style Complex CAD (5) PVD-P Valv. CM AF Sub-Clinical Arterial (2) DBD/Frailty (2) Health Political

More information

Treatment Gaps in 2ary Prevention 15 Comments Low Compliance (Life Style) & Adherence (Drugs)

Treatment Gaps in 2ary Prevention 15 Comments Low Compliance (Life Style) & Adherence (Drugs) Treatment Gaps in 2ary Prevention 15 Comments Low Compliance (Life Style) & Adherence (Drugs) 1. IOM From Warnings to Promoting Health (2) 2. Low-Compliance vs Low-Adherence Definition, Quantification

More information

CABG & OMT Evolving Again? Microcirculation & OMT+Adherence

CABG & OMT Evolving Again? Microcirculation & OMT+Adherence CABG & OMT Evolving Again? Microcirculation & OMT+Adherence ACC - Mumbai, Jan. 23, 2016 No Disclosures Revascularization for Coronary Artery Disease OMT vs PCI vs CABG 1980 s. LMD, The Rule of 2 / 3 CABG

More information

The Polypill for Secondary Prevention Is Entering the Cardiovascular Field: Worldwide Interest Based on Better Adherence and Economics

The Polypill for Secondary Prevention Is Entering the Cardiovascular Field: Worldwide Interest Based on Better Adherence and Economics The Polypill for Secondary Prevention Is Entering the Cardiovascular Field: Worldwide Interest Based on Better Adherence and Economics Jose M. Castellano, MD, PhD Clinical Trials Coordinator, CNIC, Madrid,

More information

New Paradigms in Predicting CVD Risk

New Paradigms in Predicting CVD Risk New Paradigms in Predicting CVD Risk Imaging as an Integrator of Lifetime Risk Exposure Michael J. Blaha MD MPH Presented by: Michael J. Blaha September 24, 2014 1 Talk Outline Risk factors vs. Disease

More information

40% minimum reduction from

40% minimum reduction from 160 Circulatory Disease Mortality Target: Death rates in England 1993-2006 Persons under 75 Death / 100,000 population A fall of 44% over 10 years 140 120 100 80 60 40 20 141.0 84.2 Immortality guaranteed

More information

Contribution of NCD and CVD to the Global Mortality and GBD in 1998 (LIC & MIC)

Contribution of NCD and CVD to the Global Mortality and GBD in 1998 (LIC & MIC) Contribution of NCD and CVD to the Global Mortality and GBD in 1998 (LIC & MIC) Disease Contrib of NCD s to total global mortality (%) LIC + MIC Contrib to global NCD mortality (%) Contrib of NCD s to

More information

The Problem of CV Drug Adherence Worldwide

The Problem of CV Drug Adherence Worldwide The Problem of CV Drug Adherence Worldwide Jose M. Castellano Coordinador Investigaciones Clínicas, Centro Nacional de Investigaciones Cardiovascular (CNIC) Instituto de Salud Carlos III, Madrid, Spain

More information

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Treatment of Cardiovascular Risk Factors Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Disclosures: None Objectives What do risk factors tell us What to check and when Does treatment

More information

Weintraub, W et al NEJM March Khot, UN et al, JAMA 2003

Weintraub, W et al NEJM March Khot, UN et al, JAMA 2003 Global risk hscrp Should not be included in a Global Cardiovascular Risk Assessment. Jodi Tinkel, MD Assistant Professor Director of Cardiac Rehabilitation Associate Program Director, Cardiovascular Medicine

More information

The Indian Polycap Study 1 & 2 (TIPS 1 & 2) and The International Polycap Study 3 & 4 (TIPS 3 & 4)

The Indian Polycap Study 1 & 2 (TIPS 1 & 2) and The International Polycap Study 3 & 4 (TIPS 3 & 4) The Indian Polycap Study 1 & 2 (TIPS 1 & 2) and The International Polycap Study 3 & 4 (TIPS 3 & 4) Denis Xavier MD, MSc Professor and Head, Pharmacology, St. John's Medical College Coordinator, Division

More information

The Art of Cardiovascular Risk Assessment

The Art of Cardiovascular Risk Assessment The Art of Cardiovascular Risk Assessment Laurence S. Sperling, M.D., FACC, FACP,FAHA, FASPC Professor of Medicine (Cardiology) Professor of Global Health Director- Center for Heart Disease Prevention

More information

Understanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s

Understanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s Understanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s Ho Chi Minh City, Vietnam August 7, 2014 JBS 2 Risk Guidelines (2005) Based

More information

PESA CNIC-SANTANDER STEMI

PESA CNIC-SANTANDER STEMI VF-3D-ESSOS Fuster-CNIC-Ferrer Cardiovascular Polypill and SECURE Trial ATHEROBRAIN H2H Study PESA CNIC-SANTANDER STEMI Trials: The Metoprolol program TAN SNIP VF-3D-ESSOS STUDY MRI is the gold standard

More information

9/18/2017 DISCLOSURES. Consultant: RubiconMD. Research: Amgen, NHLBI OUTLINE OBJECTIVES. Review current CV risk assessment tools.

9/18/2017 DISCLOSURES. Consultant: RubiconMD. Research: Amgen, NHLBI OUTLINE OBJECTIVES. Review current CV risk assessment tools. UW MEDICINE UW MEDICINE UCSF ASIAN TITLE HEALTH OR EVENT SYMPOSIUM 2017 DISCLOSURES Consultant: RubiconMD ESTIMATING CV RISK IN ASIAN AMERICANS AND PREVENTION OF CVD Research: Amgen, NHLBI EUGENE YANG,

More information

Cardiometabolics in Children or Lipidology for Kids. Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az

Cardiometabolics in Children or Lipidology for Kids. Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az Cardiometabolics in Children or Lipidology for Kids Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az No disclosures for this Presentation Death Risk Approximately 40% of

More information

Journal of the American College of Cardiology

Journal of the American College of Cardiology 1/5 Journal of the American College of Cardiology Volume 70, Issue 15, October 2017 DOI: 10.1016/j.jacc.2017.08.027 PDF Article The Importance of Breakfast in Atherosclerosis Disease Insights From the

More information

American Osteopathic College of Occupational and Preventive Medicine 2012 Mid-Year Educational Conference St. Petersburg, Florida

American Osteopathic College of Occupational and Preventive Medicine 2012 Mid-Year Educational Conference St. Petersburg, Florida The 21 st Century Paradigm Shift: Prevention Rather Than Intervention for the Treatment of Stable CHD The Economic Burden of Cardiovascular Diseases Basil Margolis MD, FACC, FRCP Director, Preventive Cardiology

More information

CMMI Project: San Diego A Heart Attack and Stroke Free Zone. Parag Agnihotri, MD Chair of the Healthcare Committee

CMMI Project: San Diego A Heart Attack and Stroke Free Zone. Parag Agnihotri, MD Chair of the Healthcare Committee CMMI Project: San Diego A Heart Attack and Stroke Free Zone Parag Agnihotri, MD Chair of the Healthcare Committee San Diego: A Heart Attack and Stroke Free Zone Goal Reduce heart attacks and strokes by

More information

CLINICAL STUDIES. PESA CNIC-SANTANDER Fuster-CNIC-Ferrer Cardiovascular Polypill and SECURE Trial STEMI trials: The Metroprolol program TAN SNIP AWHS

CLINICAL STUDIES. PESA CNIC-SANTANDER Fuster-CNIC-Ferrer Cardiovascular Polypill and SECURE Trial STEMI trials: The Metroprolol program TAN SNIP AWHS PESA CNIC-SANTANDER Fuster-CNIC-Ferrer Cardiovascular Polypill and SECURE Trial STEMI trials: The Metroprolol program TAN SNIP AWHS PESA CNIC-SANTANDER (Progression of Early Subclinical Atherosclerosis)

More information

The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases

The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases Eun-Jung Rhee Department of Endocrinology and Metabolism Kangbuk Samsung Hospital Sungkyunkwan

More information

How to Reduce CVD Complications in Diabetes?

How to Reduce CVD Complications in Diabetes? How to Reduce CVD Complications in Diabetes? Chaicharn Deerochanawong M.D. Diabetes and Endocrinology Unit Department of Medicine Rajavithi Hospital, Ministry of Public Health Framingham Heart Study 30-Year

More information

Short and Long Term Prognosis after Coronary Artery Calcium Scoring

Short and Long Term Prognosis after Coronary Artery Calcium Scoring Short and Long Term Prognosis after Coronary Artery Calcium Scoring In Pre-Elderly and Elderly Patients Michael J. Blaha MD MPH Presented by: Michael J. Blaha July 24, 2017 1 Talk Outline 1. Coronary artery

More information

Environmental. Vascular / Tissue. Metabolics

Environmental. Vascular / Tissue. Metabolics Global Risk Reduction--WINS Picking Mom and Dad-2016 Environmental Vascular / Tissue Metabolics Stop smoking-1b Physical activity-1b Weight control-1b Chelation therapy-3c Influenza vaccination-1b Blood

More information

Global Burden of Cardiovascular Disease Global Efforts in Achieving 25 x 25

Global Burden of Cardiovascular Disease Global Efforts in Achieving 25 x 25 Global Burden of Cardiovascular Disease Global Efforts in Achieving 25 x 25 William A. Zoghbi MD, MACC Elkins Family Distinguished Chair in Cardiac Health Professor and Chairmen, Department of Cardiology

More information

Reducing CVD globally through combination approaches to prevention: the polypill. Salim Yusuf

Reducing CVD globally through combination approaches to prevention: the polypill. Salim Yusuf Reducing CVD globally through combination approaches to prevention: the polypill. Salim Yusuf Disclosure None Polypill & CVD Prevention 1. Why do we need a polypill? 2. What components in the polypill?

More information

Subclinical AF: Implications of device based episodes

Subclinical AF: Implications of device based episodes Subclinical AF: Implications of device based episodes Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC Disclosures: Clinical Trials and Consulting: Medtronic, Boston Scientific

More information

The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases

The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases Eun-Jung Rhee Department of Endocrinology and Metabolis Kangbuk Samsung Hospital Sungkyunkwan

More information

Kanyini Guidelines Adherence with the Polypill (Kanyini GAP)

Kanyini Guidelines Adherence with the Polypill (Kanyini GAP) Kanyini Guidelines Adherence with the Polypill (Kanyini GAP) Disclosures Funded by the National Health and Medical Research Council of Australia. Dr Reddy s Laboratories Ltd manufactured and supplied polypills

More information

WHO global response to salt reduction strategies

WHO global response to salt reduction strategies WHO global response to salt reduction strategies Dr Godfrey C Xuereb Team Leader Population-based Prevention Team SPP Unit Prevention of Noncommunicable Diseases Department The World Health Organization

More information

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention

More information

Rajeev K. Pathak MBBS, PhD. Department of Cardiac Electrophysiology Hospital of University of Pennsylvania

Rajeev K. Pathak MBBS, PhD. Department of Cardiac Electrophysiology Hospital of University of Pennsylvania Rajeev K. Pathak MBBS, PhD Department of Cardiac Electrophysiology Hospital of University of Pennsylvania Nil Applicable Disclosure Proportion overweight 70% 60% 50% 40% USA Australia England 30% France

More information

Prevention: When Do Benefits Start and End? What Do They Have in Common?

Prevention: When Do Benefits Start and End? What Do They Have in Common? Prevention: When Do Benefits Start and End? Providence Internal Medicine Spring Symposium April 14, 2016 Mari Kai, MD What Do They Have in Common? 82 year old female 62 year old male Estimated Life Expectancy

More information

Prevalence of Cardiac Risk Factors among People Attending an Exhibition

Prevalence of Cardiac Risk Factors among People Attending an Exhibition IOSR Journal of Nursing and Health Science (IOSR-JNHS) e-issn: 2320 1959.p- ISSN: 2320 1940 Volume 3, Issue 6 Ver. IV (Nov.-Dec. 2014), PP 4-51 Prevalence of Cardiac Risk Factors among People Attending

More information

Case Presentation. Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer

Case Presentation. Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer Case Presentation Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer Case Presentation 50 YO man NSTEMI treated with PCI 1 month ago Medical History: Obesity: BMI 32,

More information

Placebo-Controlled Statin Trials MANAGEMENT OF HIGH BLOOD CHOLESTEROL MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES

Placebo-Controlled Statin Trials MANAGEMENT OF HIGH BLOOD CHOLESTEROL MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest

More information

Arterial function and longevity Focus on the aorta

Arterial function and longevity Focus on the aorta Arterial function and longevity Focus on the aorta Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Secrets of longevity Secrets of longevity Unveiling

More information

Mean INTERHEART Risk Score (IHRS) Yusuf et al NEJM 2014

Mean INTERHEART Risk Score (IHRS) Yusuf et al NEJM 2014 Mean INTERHEART Risk Score (IHRS) Yusuf et al NEJM 2014 CVD Event Rates Major CVD = death from CV causes, stroke, MI and HF Non major CVD = all other CVD events that led to hospitalization Yusuf et al

More information

Assessing atherosclerotic risk for long term preventive treatment

Assessing atherosclerotic risk for long term preventive treatment Assessing atherosclerotic risk for long term preventive treatment Donald A. Smith, MD, MPH Endocrinologist, Clinical Lipidologist Associate Professor of Medicine and Preventive Medicine Icahn School of

More information

National health-care expenditures are projected to rise to $5.2 trillion by 2023

National health-care expenditures are projected to rise to $5.2 trillion by 2023 National health-care expenditures are projected to rise to $5.2 trillion by 2023 US$ trillions 6 5 4 3 2.3 2.5 2.7 2.9 3.2 3.6 4.0 4.6 5.2 2 1 0 2007 2011 2015* 2019* 2023* * Projected. Source: Centers

More information

The Engaged Patient: Understanding and Participating in Shared Health Decisions

The Engaged Patient: Understanding and Participating in Shared Health Decisions The Engaged Patient: Understanding and Participating in Shared Health Decisions By Tom Bartol, NP Richmond Area Health Center HealthReach Community Health Centers bartolnp@gmail.com Twitter: @tombartol

More information

CVD risk assessment using risk scores in primary and secondary prevention

CVD risk assessment using risk scores in primary and secondary prevention CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities

More information

New ACC/AHA Guidelines on Lipids: Are PCSK9 Inhibitors Poised for a Breakthrough?

New ACC/AHA Guidelines on Lipids: Are PCSK9 Inhibitors Poised for a Breakthrough? New ACC/AHA Guidelines on Lipids: Are PCSK9 Inhibitors Poised for a Breakthrough? Sidney C. Smith, Jr. MD, FACC, FAHA Professor of Medicine/Cardiology University of North Carolina at Chapel Hill Immediate

More information

Goals of Screening Programs. What is Vascular Screening? Assumptions Regarding the Potential Benefits of Screening Programs PAD

Goals of Screening Programs. What is Vascular Screening? Assumptions Regarding the Potential Benefits of Screening Programs PAD Conflict of Interest Disclosure (Relationships with Industry) An Epidemic of : The Debate Over Population Screening Membership on an advisory board, consultant, or recipient of a research grant from the

More information

James M. Kirshenbaum, MD, FACC

James M. Kirshenbaum, MD, FACC James M. Kirshenbaum, MD, FACC Associate Professor of Medicine Harvard Medical School Co-Director, Clinical Cardiology Director, Acute Interventional Cardiology Brigham and Women s Hospital Boston, MA

More information

The Demise of Mr. Homo sapiens

The Demise of Mr. Homo sapiens The Demise of Mr. Homo sapiens June 12, 2013 Bruce B. Campbell, MD Chair, Department of Executive Health Associate Clinical Professor of Medicine Tufts University School of Medicine Lahey Clinic Age 85

More information

Cardiovascular Risk Assessment and Management Making a Difference

Cardiovascular Risk Assessment and Management Making a Difference Cardiovascular Risk Assessment and Management Making a Difference Norman Sharpe March 2014 Numbers and age-standardised mortality rates from all causes, by sex, 1950 2010 Death rates halved Life expectancy

More information

The importance of follow-up after a cardiac event: CARDIAC REHABILITATION. Dr. Guy Letcher

The importance of follow-up after a cardiac event: CARDIAC REHABILITATION. Dr. Guy Letcher The importance of follow-up after a cardiac event: CARDIAC REHABILITATION Dr. Guy Letcher The National Medicare Experience Mortality After Angioplasty 225,915 patients Mortality After Bypass Surgery 357,885

More information

The Heart of a Woman. Karen E. Friday, M.D. Associate Professor of Medicine Section of Endocrinology Louisiana State University School of Medicine

The Heart of a Woman. Karen E. Friday, M.D. Associate Professor of Medicine Section of Endocrinology Louisiana State University School of Medicine The Heart of a Woman Karen E. Friday, M.D. Associate Professor of Medicine Section of Endocrinology Louisiana State University School of Medicine American Heart Association Women, Heart Disease and Stroke

More information

21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease

21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease 21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease Noninvasive Evaluation of Coronary Artery Disease: Anatomical, Functional, Clinical May 5, 2018 Mark Hansen MD FRCPC Cardiologist,

More information

Cardiovascular Complications of Diabetes

Cardiovascular Complications of Diabetes VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary

More information

Hypertension Guidelines JNC Recommendations. Robert E. Bulow DO FACOI, FACC

Hypertension Guidelines JNC Recommendations. Robert E. Bulow DO FACOI, FACC Hypertension Guidelines JNC Recommendations Robert E. Bulow DO FACOI, FACC None Disclosures Question At what blood pressure should pharmacologic therapy be initiated in the non diabetic pt with age greater

More information

Beyond 2018: Sharing Million Hearts Lessons and Road Rash. Building the Bridge Beyond 2018 National Colorectal Cancer Round Table December 7, 2017

Beyond 2018: Sharing Million Hearts Lessons and Road Rash. Building the Bridge Beyond 2018 National Colorectal Cancer Round Table December 7, 2017 Beyond 2018: Sharing Million Hearts Lessons and Road Rash Building the Bridge Beyond 2018 National Colorectal Cancer Round Table December 7, 2017 Janet Wright MD FACC Disclaimer The opinions expressed

More information

CVD risk estimation in populations with high prevalence of MetS. Dilek Ural, 12 March 2017 Koç University, Istanbul

CVD risk estimation in populations with high prevalence of MetS. Dilek Ural, 12 March 2017 Koç University, Istanbul CVD risk estimation in populations with high prevalence of MetS Dilek Ural, 12 March 2017 Koç University, Istanbul Understanding CV risk Likelihood of a person developing an atherosclerotic CV event over

More information

5/2/2016. Outpatient Stroke Management Sheila Smith MD May 5, 2016

5/2/2016. Outpatient Stroke Management Sheila Smith MD May 5, 2016 Outpatient Stroke Management Sheila Smith MD May 5, 2016 1 Management of Outpatient Stroke Objectives Review blood pressure management post stroke Review antithrombotic therapy Review statin therapy Discuss

More information

Biomarkers and undiagnosed disease

Biomarkers and undiagnosed disease Biomarkers and undiagnosed disease Soham Al Snih, MD, Ph.D The University of Texas Medical Branch, Galveston, TX May 29, 2015 Mexico City, Mexico Biomarkers Broad subcategory of medical signs Objective

More information

STEMI: Evolving Early Therapies of Myocardial Ischemia/Reperfusion Injury.

STEMI: Evolving Early Therapies of Myocardial Ischemia/Reperfusion Injury. STEMI: Evolving Early Therapies of Myocardial Ischemia/Reperfusion Injury. Borja Ibanez, MD PhD FESC. - Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC). - Hospital Clínico San Carlos.

More information

Global Variability in NCDs PURE

Global Variability in NCDs PURE Global Variability in NCDs PURE (Prospective Urban Rural Epidemiology) study CLEAN COOKING AND NCD INDICATORS/ BIOMARKERS MEETING WASHINGTON DC, DEC 16 2014 MyLinh Duong MBBS FRACP On behalf of PURE Investigators

More information

Percutaneous Management of Severe AS in Octagenarians. Phillip Matsis FRACP FCSANZ Interventional Cardiologist Wakefield Heart Centre Wellington

Percutaneous Management of Severe AS in Octagenarians. Phillip Matsis FRACP FCSANZ Interventional Cardiologist Wakefield Heart Centre Wellington Percutaneous Management of Severe AS in Octagenarians Phillip Matsis FRACP FCSANZ Interventional Cardiologist Wakefield Heart Centre Wellington May 2017 Outline Aetiology of AS Natural History of AS Assessment

More information

Coronary Artery Calcium. Vimal Ramjee, MD FACC The Chattanooga Heart Institute

Coronary Artery Calcium. Vimal Ramjee, MD FACC The Chattanooga Heart Institute Coronary Artery Calcium Vimal Ramjee, MD FACC The Chattanooga Heart Institute Disclosures I have no conflicts of interest to disclose. Objectives Recognize the utility of coronary artery calcium scoring

More information

Is it worth offering cardiovascular disease prevention to the elderly? Prof. Dr. Helmut Gohlke Herz-Zentrum Bad Krozingen, Germany

Is it worth offering cardiovascular disease prevention to the elderly? Prof. Dr. Helmut Gohlke Herz-Zentrum Bad Krozingen, Germany Is it worth offering cardiovascular disease prevention to the elderly? Prof. Dr. Helmut Gohlke Herz-Zentrum Bad Krozingen, Germany Is it worth offering cardiovascular disease prevention to the elderly?

More information

Causes of death in Diabetes

Causes of death in Diabetes Rates of CV events in Diabetes patients Respiratory4.2 Cancer 7.6 Diabetes 1.3 CV disease 17.3 Causes of death in Diabetes 250 200 150 100 50 0 per 10,000 person-years 97 151 243 Framingham 5 X increase

More information

Page 1. Disclosures. Background. No disclosures

Page 1. Disclosures. Background. No disclosures Population-Based Lipid Screening in the Era of a Childhood Obesity Epidemic: The Importance of Non-HDL Cholesterol Assessment Brian W. McCrindle, Cedric Manlhiot, Don Gibson, Nita Chahal, Helen Wong, Karen

More information

Lifetime clinical and economic benefits of statin-based LDL lowering in the 20-year Followup of the West of Scotland Coronary Prevention Study

Lifetime clinical and economic benefits of statin-based LDL lowering in the 20-year Followup of the West of Scotland Coronary Prevention Study Lifetime clinical and economic benefits of statin-based LDL lowering in the 20-year Followup of the West of Scotland Coronary Prevention Study Harvey White Green Lane Cardiovascular Service and Cardiovascular

More information

Current and Future Imaging Trends in Risk Stratification for CAD

Current and Future Imaging Trends in Risk Stratification for CAD Current and Future Imaging Trends in Risk Stratification for CAD Brian P. Griffin, MD FACC Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic Disclosures: None Introduction

More information

Lipid Management: The Next Level How Will the New ACC/AHA Guidelines Change My Practice

Lipid Management: The Next Level How Will the New ACC/AHA Guidelines Change My Practice Lipid Management: The Next Level How Will the New ACC/AHA Guidelines Change My Practice Vera Bittner, MD, MSPH Professor of Medicine Section Head, Preventive Cardiology Medical Director, Cardiac Rehabilitation

More information

Polypill in the Management of Secondary Preven6on in La6n America: A Look at the Future

Polypill in the Management of Secondary Preven6on in La6n America: A Look at the Future Polypill in the Management of Secondary Preven6on in La6n America: A Look at the Future Alvaro Sosa Liprandi MD, MTSAC, FACC Head of Cardiology. Sanatorio Güemes, Buenos Aires. Argentina Director. Lezica

More information

CT Calcium Score and Statins in Primary CV Prevention. Dr Selwyn Wong

CT Calcium Score and Statins in Primary CV Prevention. Dr Selwyn Wong CT Calcium Score and Statins in Primary CV Prevention. Dr Selwyn Wong Promises, Pitfalls and Hard Truths of Coronary Calcium Scanning Selwyn Wong Ascot and Middlemore Hospitals Coronary Calcium Scoring

More information

What s the evidence, why do guidelines differ, and what should the GP do?

What s the evidence, why do guidelines differ, and what should the GP do? What s the evidence, why do guidelines differ, and what should the GP do? Richard McManus Barcelona 2018 Overview What is hypertension? How should blood pressure be measured/diagnosed? What should we be

More information

Population Health Research Institute. Who we are

Population Health Research Institute. Who we are Population Health Research Institute Who we are We are an Academic Research Organization Founded in 1999 as a joint research institute of: McMaster University and Hamilton Health Sciences Corporation.

More information

Cardiac patient quality of life. How to eat adequately?

Cardiac patient quality of life. How to eat adequately? Cardiac patient quality of life How to eat adequately? François Paillard CV Prevention Center CHU Rennes JESFC, Paris, 17/01/2013 Mrs. L. 55 yrs, Coronary artery disease, normal weight, mild hypertension

More information

Reducing the Population Health Burden of Cardiovascular Disease

Reducing the Population Health Burden of Cardiovascular Disease Reducing the Population Health Burden of Cardiovascular Disease Joseph A. Ladapo, MD, PhD Assistant Professor of Medicine Department of Population Health NYU School of Medicine Disclosures: K23 HL116787

More information

Management of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018

Management of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018 Management of Stable Ischemic Heart Disease Vinay Madan MD February 10, 2018 1 Disclosure No financial disclosure. 2 Overview of SIHD Diagnosis Outline of talk Functional vs. Anatomic assessment Management

More information

Vascular and Degenerative Causes of Cognitive Impairment: How are they linked?

Vascular and Degenerative Causes of Cognitive Impairment: How are they linked? Vascular and Degenerative Causes of Cognitive Impairment: How are they linked? MCI Symposium, Public Education Forum Presented by: Rebecca Gottesman, MD PhD January 20, 2019 1 Disclosures I am an Associate

More information

Breast Cancer and the Heart

Breast Cancer and the Heart Breast Cancer and the Heart Anne H. Blaes, M.D., M.S. Associate Professor University of Minnesota Hematology/Oncology Director, Adult Cancer Survivor Clinic No disclosures Objectives Discuss cardiac complications

More information

Developments in the Caribbean - The Impact of Chronic Diseases. Dr. Glennis Andall-Brereton Caribbean Epidemiology Centre

Developments in the Caribbean - The Impact of Chronic Diseases. Dr. Glennis Andall-Brereton Caribbean Epidemiology Centre Developments in the Caribbean - The Impact of Chronic Diseases Dr. Glennis Andall-Brereton Caribbean Epidemiology Centre Overview of Presentation Epidemiology Mortality Morbidity and Risk Factors The Way

More information

Mitral Valve Reference Center. Ariana González Gómez Heart Valve Clinic. University Hospital Ramón y Cajal. Madrid. Spain.

Mitral Valve Reference Center. Ariana González Gómez Heart Valve Clinic. University Hospital Ramón y Cajal. Madrid. Spain. Mitral Valve Reference Center Ariana González Gómez Heart Valve Clinic. University Hospital Ramón y Cajal. Madrid. Spain. Introduction MICLIP STUDY Prevalence of MR in patients undergoing clinically indicated

More information

Blood Pressure Measurement in SPRINT

Blood Pressure Measurement in SPRINT Blood Pressure Measurement in SPRINT Karen C. Johnson, MD, MPH, FAHA Vice Chair, SPRINT Steering Committee University of Tennessee Health Science Center, Department of Preventive Medicine For the SPRINT

More information

CARE PATHWAYS. Allyson Ashley

CARE PATHWAYS. Allyson Ashley CARE PATHWAYS Allyson Ashley WHAT IS A CARE PATHWAY? An explicit statement of the goals and key elements of care based on evidence, best practice, and patient s expectations and their characteristics The

More information

João A. C. Lima, MD Professor of Medicine and Radiology Johns Hopkins Hospital

João A. C. Lima, MD Professor of Medicine and Radiology Johns Hopkins Hospital CARDIOVASCULAR MRI Tower Health, Reading, May 12, 2018 João A. C. Lima, MD Professor of Medicine and Radiology Johns Hopkins Hospital Disclosures Cannon Medical Systems Grant Funds Contracted Research

More information

The PESA-CNIC-Santander Study (Progression of Early Subclinical Atherosclerosis)

The PESA-CNIC-Santander Study (Progression of Early Subclinical Atherosclerosis) XXXIV LECCIÓN MEMORIAL Fundación Fernández-Cruz Today Moving Frontiers to Stay Healthy and Living Well Forever The PESA-CNIC-Santander Study (Progression of Early Subclinical Atherosclerosis) Antonio Fernández-Ortiz

More information

Placebo-Controlled Statin Trials Prevention Of CVD in Women"

Placebo-Controlled Statin Trials Prevention Of CVD in Women MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest

More information

Red Alert for Women s Hearts Women and Cardiovascular Research in Europe

Red Alert for Women s Hearts Women and Cardiovascular Research in Europe Red Alert for Women s Hearts Women and Cardiovascular Research in Europe Marco Stramba-Badiale Director, Department of Rehabilitation Medicine, IRCCS Istituto Auxologico Italiano, Milan, Italy European

More information

Fasting or non fasting?

Fasting or non fasting? Vascular harmony Robert Chilton Professor of Medicine University of Texas Health Science Center Director of Cardiac Catheterization labs Director of clinical proteomics Which is best to measure Lower continues

More information

Atrial Fibrillation & Acute Stroke

Atrial Fibrillation & Acute Stroke Atrial Fibrillation & Acute Stroke Acute Stroke Stroke Facts Aetiology Thrombosis Classification outcomes Time is Brain Acute Stroke Over 5 million people die as a result of stroke and another 5 million

More information

Antithrombotic Therapy for Long-Term Secondary Prevention Considerations for Long-Term DAPT

Antithrombotic Therapy for Long-Term Secondary Prevention Considerations for Long-Term DAPT Antithrombotic Therapy for Long-Term Secondary Prevention Considerations for Long-Term DAPT Marc P. Bonaca, MD, MPH Vascular Section, Cardiovascular Division Investigator TIMI Study Group Brigham and Women

More information

Hyperlipidemia in an Otherwise Healthy 80 Year-Old Patient. Theodore D Fraker, Jr, MD Professor of Medicine

Hyperlipidemia in an Otherwise Healthy 80 Year-Old Patient. Theodore D Fraker, Jr, MD Professor of Medicine Hyperlipidemia in an Otherwise Healthy Theodore D Fraker, Jr, MD Professor of Medicine Orlando, Florida October 7-9, 2011 80-Year-Old Patient Primary Prevention Issues in the Elderly: Coronary artery disease

More information

Placebo-Controlled Statin Trials

Placebo-Controlled Statin Trials PREVENTION OF CHD WITH LIPID MANAGEMENT AND ASPIRIN: MATCHING TREATMENT TO RISK Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of

More information

Cottrell Memorial Lecture. Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease?

Cottrell Memorial Lecture. Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease? Cottrell Memorial Lecture Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease? Stephen Nicholls MBBS PhD @SAHMRI_Heart Disclosures Research support: AstraZeneca,

More information

Reducing Inflammation to Reduce Cardiovascular Risk: The Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)

Reducing Inflammation to Reduce Cardiovascular Risk: The Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) New York City Cardiovascular Symposium December 10, 2017 Reducing Inflammation to Reduce Cardiovascular Risk: The Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) Paul M Ridker, MD, MPH

More information

Association between arterial stiffness and cardiovascular risk factors in a pediatric population

Association between arterial stiffness and cardiovascular risk factors in a pediatric population + Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro

More information

Managing HTN in the Elderly: How Low to Go

Managing HTN in the Elderly: How Low to Go Managing HTN in the Elderly: How Low to Go Laxmi S. Mehta, MD, FACC The Ohio State University Medical Center Assistant Professor of Clinical Internal Medicine Clinical Director of the Women s Cardiovascular

More information

Setting priorities for public health in the EU Italian national experience

Setting priorities for public health in the EU Italian national experience Setting priorities for public health in the EU Italian national experience Giovanni Nicoletti Office of the Secretary General Ministry of health - Italy EHFG Bad Hofgastein 4.10.2018 NCDs : Italian situation

More information

Prospective Urban Rural Epidemiologic ( PURE) Study.

Prospective Urban Rural Epidemiologic ( PURE) Study. Prospective Urban Rural Epidemiologic ( PURE) Study. 17 HIC, MIC and LIC countries, 628 urban and rural communities, 154,000 randomly selected, BP measured using an Omron with standard methods in 90%.

More information

PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN

PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN 1980 to 2000: Death rate fell from: 542.9 to 266.8 per 100K men 263.3 to 134.4 per 100K women 341,745 fewer deaths from CHD in 2000 Ford ES, NEJM, 2007 47% from CHD treatments, 44% from risk factor modification

More information